Tiny study compares trazodone and quetiapine for ICU delirium – but was cut short

NCT ID NCT05307003

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study aimed to compare trazodone and quetiapine for treating delirium in ICU patients. It enrolled only 10 adults in the surgical ICU who had delirium with symptoms like agitation or hallucinations. The study was terminated early, so the results are very limited and cannot provide clear answers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Trazodone and quetiapine

What this could lead to

If successful, this could suggest a better option for managing ICU delirium with fewer side effects.

What could go wrong

This was a very small pilot study (only 10 participants) that was terminated early, so the findings are not reliable or generalizable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELIRIUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Confusion delirium psychiatric disorder Sepsis-Associated Encephalopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Keck Hospital of the University of Southern California

    Los Angeles, California, 90033, United States